VitsGen: Targeted Radiotherapy

English 简体中文

18 2025-09

VitsGen’s IND for Novel PSMA-Targeting Radioligand Therapy (177Lu-PSMA-VG01) in mCRPC Accepted by China’s CDE
03 2025-06

VitsGen 21st Century Medicinal Chemistry Delivering Precision Radioligand Therapy
18 2025-03

VitsGen CEO & CSO Invited Speakers at TRP US
26 2024-08

Meeting VitsGen Therapeutics, Inc. at SNMMI 2024 Therapeutics Conference, Booth #13

Total 4 record(s)1

Copyright © VitsGen All Rights Reserved. All copies are strictly prohibited without permission